{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:31:08Z","timestamp":1786995068857,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.nmd.2009.01.002","type":"journal-article","created":{"date-parts":[[2009,2,9]],"date-time":"2009-02-09T04:13:07Z","timestamp":1234152787000},"page":"223-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Immune-mediated rippling muscle disease with myasthenia gravis: A report of seven patients with long-term follow-up in two"],"prefix":"10.1016","volume":"19","author":[{"given":"Benedikt","family":"Schoser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiju","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hilton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"M\u00fcller-Felber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kubisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Van den","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nmd.2009.01.002_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0404.1975.tb07603.x","article-title":"A family with dominant hereditary myotonia, muscular hypertrophy, and increased muscular irritability, distinct from myotonia congenita Thomsen","volume":"51","author":"Torbergsen","year":"1975","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.nmd.2009.01.002_bib2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/90050","article-title":"Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease","volume":"28","author":"Betz","year":"2001","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.nmd.2009.01.002_bib3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.62.4.538","article-title":"Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases","volume":"62","author":"Woodman","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nmd.2009.01.002_bib4","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.52.7.1453","article-title":"Phenotypic variability in rippling muscle disease","volume":"52","author":"Vorgerd","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2009.01.002_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.10501","article-title":"Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease","volume":"53","author":"Kubisch","year":"2003","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.nmd.2009.01.002_bib6","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1212\/WNL.57.12.2273","article-title":"A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation","volume":"57","author":"Vorgerd","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2009.01.002_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archneur.1989.00520400065020","article-title":"Rippling muscle disease","volume":"46","author":"Ricker","year":"1989","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.nmd.2009.01.002_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae","volume":"8","author":"Parton","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.nmd.2009.01.002_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.20350","article-title":"Autosomal recessive rippling muscle disease with homozygous CAV3 mutations","volume":"57","author":"Kubisch","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2009.01.002_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.1996.00550020113023","article-title":"Rippling muscles and myasthenia gravis with rippling muscles","volume":"53","author":"Ansevin","year":"1996","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.nmd.2009.01.002_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1212\/01.WNL.0000068529.36993.03","article-title":"Autoimmune rippling muscle","volume":"61","author":"Ashok Muley","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nmd.2009.01.002_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.54.1.273","article-title":"Phenotypic variability in rippling muscle disease","volume":"54","author":"Ansevin","year":"2000","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.nmd.2009.01.002_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0960-8966(99)00065-6","article-title":"Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis","volume":"9","author":"Muller-Felber","year":"1999","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2009.01.002_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mus.10494","article-title":"Acquired rippling muscle disease with myasthenia gravis","volume":"29","author":"Greenberg","year":"2004","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nmd.2009.01.002_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.WNL.0000149532.52938.5B","article-title":"Immune-mediated rippling muscle disease","volume":"64","author":"Schulte-Mattler","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2009.01.002_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2169\/internalmedicine.41.147","article-title":"Rippling muscle syndrome preceding malignant lymphoma","volume":"41","author":"Takagi","year":"2002","journal-title":"Int Med"},{"issue":"1","key":"10.1016\/j.nmd.2009.01.002_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jcb.20857","article-title":"Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patients","volume":"99","author":"Watkins","year":"2006","journal-title":"J Cell Biochem"},{"issue":"9","key":"10.1016\/j.nmd.2009.01.002_bib18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.41.9.1497","article-title":"Inflammation at the neuromuscular junction in myasthenia gravis","volume":"41","author":"Maselli","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2009.01.002_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ncpneuro0033","article-title":"Autoimmune channelopathies","volume":"1","author":"Buckley","year":"2005","journal-title":"Nat Clin Prac Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2009.01.002_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.10442","article-title":"Consequences of a novel caveolin-3 mutation in a large German family","volume":"53","author":"Fischer","year":"2003","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.nmd.2009.01.002_bib21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/jnnp.2003.028217","article-title":"Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease","volume":"75","author":"Van den Bergh","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.nmd.2009.01.002_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/hmg\/ddi434","article-title":"Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3","volume":"15","author":"Hernandez-Deviez","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.nmd.2009.01.002_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2353\/ajpath.2007.060687","article-title":"Caveolin-1(-\/-)- and caveolin-2(-\/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation","volume":"170","author":"Schubert","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2009.01.002_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1006\/bbrc.1999.1534","article-title":"Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: Possible relationship of antigens and stretch-activated ion channels","volume":"264","author":"Walker","year":"1999","journal-title":"Biochem Biophy Res Commun"},{"issue":"9","key":"10.1016\/j.nmd.2009.01.002_bib25","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","article-title":"Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?","volume":"57","author":"Buckley","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nmd.2009.01.002_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10158-007-0051-5","article-title":"Muscular dystrophy associated mutations in caveolin-1 induce neurotransmission and locomotion defects in Caenorhabditis elegans","volume":"7","author":"Parker","year":"2007","journal-title":"Invert Neurosci"},{"issue":"9","key":"10.1016\/j.nmd.2009.01.002_bib27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1177\/002215540305100901","article-title":"Concentration of caveolin-3 at the neuromuscular junction in young and old rat skeletal muscle fibers","volume":"51","author":"Carlson","year":"2003","journal-title":"J Histochem Cytochem"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896609000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896609000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:57:00Z","timestamp":1760774220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896609000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0960896609000042"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2009.01.002","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated rippling muscle disease with myasthenia gravis: A report of seven patients with long-term follow-up in two","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2009.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}